Companies often use “GMP certificate”, “MRA” and “PIC/S” as if they meant the same thing. They do not, and mixing them up leads to wrong assumptions about whether a site’s compliance will be accepted in the EU.
The GMP certificate and EudraGMDP
After an inspection that shows compliance, EU authorities issue a GMP certificate for the site, and a statement of non-compliance if the inspection finds serious problems. Both are recorded in EudraGMDP, the Union database on manufacturing, importation and distribution authorisations, GMP certificates and non-compliance statements. A certificate is specific to the site, to the activities inspected and the product categories listed, so a certificate does not by itself show that a particular product is covered.
Mutual recognition agreements
An MRA is a legally binding agreement between the EU and another jurisdiction. Each party accepts the other’s GMP inspection results for covered product categories. The EU has such agreements with Australia, Canada, Israel, Japan, New Zealand, Switzerland and the United States. They differ in scope and some exclude categories such as advanced therapy medicinal products, and in some cases batch testing on import can be waived. The EMA publishes current details, and these should be checked for each case.
PIC/S
The Pharmaceutical Inspection Co-operation Scheme is a non-binding, informal cooperative arrangement among regulatory authorities in the field of GMP. It currently brings together 57 participating authorities, according to its website, and aims to harmonise GMP standards and inspection quality. Membership demonstrates that an authority operates a comparable inspection system, but it does not create legal acceptance of that authority’s inspections in the EU.
What this means in practice
- A PIC/S member’s certificate does not by itself satisfy EU requirements for a third-country manufacturing site.
- Where an MRA covers the product and the site, the partner authority’s inspection can be relied on.
- Where neither applies, EU authorities may need to inspect, or the QP must obtain assurance by other means, such as audit.
- When selecting contract manufacturers, check the EudraGMDP entry, the date of the last inspection and the scope, not only the existence of a certificate.
Due diligence before relying on a certificate
Check that the certificate is current, that the dosage forms and activities of interest are within its scope, and that no non-compliance statement has been issued since. Where there is any doubt, a direct request to the supplier or the authority, and your own audit, give stronger assurance than a document alone.
How PQRA helps
PQRA can help verify the GMP status of manufacturing and testing sites in the EudraGMDP and relevant databases, assess which recognition route applies to a given supply chain, and plan audits where inspection reliance is unavailable.
Contact PQRA to discuss the GMP status of your supply chain.


No responses yet